Dishman Group to invest USD 50 mn for setting up drug manufacturing facility in France
The new facility would begin commercial production from January 2023 with two manufacturing lines, said Harshil Dalal, global chief financial officer of Dishman Carbogen Amcis, a contract research and manufacturing services (CRAMS) player having 25 facilities across the globe
Gujarat-headquartered drug developer Dishman Carbogen Amcis Ltd (DCAL) will invest USD 50 million in France to set up a new facility for manufacturing formulated products. Source: Website